Samalin, L.
Honciuc, M.
Boyer, L.
de Chazeron, I.
Blanc, O.
Abbar, M.
Llorca, P. M.
Funding for this research was provided by:
French Ministry of Health (PREPS 2016 16-207)
Article History
Received: 4 December 2017
Accepted: 8 April 2018
First Online: 13 April 2018
Ethics approval and consent to participate
: The study was approved by the Ile de France 1 ethical committee (2017-juil.-14,602 ND). All participants have to give written informed consent.
: L.S. Dr. Samalin has received grants, honoraria, or consulting fees from AstraZeneca, Bristol-Myers Squibb, Janssen-Cilag, Lundbeck, Otsuka, Sanofi-Aventis, and Takeda.M.A. has received grants, honoraria, or consulting fees from AstraZeneca, Bristol-Myers Squibb, Janssen-Cilag, Lundbeck and Otsuka.P.M.L. has received grants, honoraria, or consulting fees from AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Ferrer, Janssen-Cilag, Lundbeck, Otsuka, Sanofi-Aventis, Servier, and Takeda.M.H., L.B., I.C. and O.B. declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.